ACLA Press Releases

  • ACLA Announces Key Staff Promotions

    January 09, 2020
    WASHINGTON, D.C.—The American Clinical Laboratory Association (ACLA) today announced the promotions of Thomas Sparkman to Senior Vice President of Government Affairs and Policy, and Andrew Young to Senior Coordinator. “Over the past seven years, Tom has been instrumental in advancing ACLA’s key priorities in front of Congress and the Administration, including recent passage of the Laboratory Access for Beneficiaries (LAB) Act,” said Julie Khani,Continue Reading »...
  • In Latest Reply Brief, ACLA responds to HHS’s Cross-Motion For Summary Judgment

    December 23, 2019
    WASHINGTON, D.C. – As litigation continues in the American Clinical Laboratory Association’s legal challenge against the U.S. Department of Health and Human Services (HHS), ACLA has filed a new reply brief in response to HHS’s cross-motion for summary judgment. The latest brief in ACLA v. Azar reinforces the association’s argument that HHS failed to implement the Protecting Access to Medicare Act (PAMA) as CongressContinue Reading »...
  • Congress Passes The LAB Act, Paving The Way For Future PAMA Reform

    December 19, 2019
    As seniors brace for a new set of cuts to clinical lab services in January, Congress takes decisive action to halt faulty data collection process responsible for year-over-year cuts to Medicare lab benefits – Independent study will assess how to improve data reporting under PAMA   WASHINGTON, D.C. – In a victory for 53 million seniors who depend on clinical laboratory diagnostics for theirContinue Reading »...
  • ACLA Announces 60 Minutes Correspondent and Author Scott Pelley as Keynote Speaker for 2020 Annual Meeting  

    December 16, 2019
    WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today announced that Scott Pelley, 60 Minutes correspondent and former anchor and managing editor of the CBS Evening News, will deliver the keynote address during the association’s Annual Meeting on March 4, 2020. Pelley, a legendary storyteller who recently published a memoir, Truth Worth Telling, will share reflections on his career and provide insight onContinue Reading »...
  • ACLA Applauds Introduction of the LAB Act in the Senate

    December 13, 2019
    WASHINGTON, D.C. – Ahead of a crucial deadline to safeguard seniors’ access to lifesaving clinical laboratory services, Sen. Richard Burr (R-NC) and Sen. Sherrod Brown (D-OH) introduced the Laboratory Access for Beneficiaries (LAB) Act, bipartisan legislation to address critical data collection deficiencies resulting in year-over-year cuts to Medicare lab benefits.   Like its counterpart in the House of Representatives (H.R. 3584), the Senate billContinue Reading »...
  • ACLA Outlines Key Changes Required to Protect Beneficiaries’ Access to Cancer Testing

    December 03, 2019
    WASHINGTON, D.C. – Recent proposals from the Centers for Medicare & Medicaid Services (CMS) would have widespread, detrimental consequences on cancer care for millions of Medicare beneficiaries, specifically for patients with a genetic predisposition for breast and ovarian cancer. In new comments submitted to the agency, the American Clinical Laboratory Association (ACLA) called on CMS to remove barriers to coverage of germline tests usingContinue Reading »...
  • As Seniors’ Lab Benefits Hang In The Balance, Leading Stakeholder Groups Urge Congress To Pass LAB Act In End-of-Year Legislation

    December 03, 2019
    WASHINGTON, D.C.— In a new letter to Congressional leadership, more than 33 stakeholder groups are urging lawmakers to pass commonsense, bipartisan reforms that would take steps to mitigate the ongoing harm facing more than 53 million seniors who depend on vital clinical laboratory services. The letter reinforces the urgent need for Congress to immediately advance H.R. 3584 – The Laboratory Access for Beneficiaries (LAB)Continue Reading »...
  • With Seniors’ Lab Access on the Line, LAB Act Gains Bipartisan Support 

    November 20, 2019
    The LAB Act would delay the upcoming PAMA reporting period to improve data collection processes and ensure sustainable, market-based rates for laboratory services WASHINGTON, D.C. — Growing bipartisan support to protect seniors’ laboratory benefits reinforces the urgent need for Congress to immediately advance H.R. 3584 – The Laboratory Access for Beneficiaries (LAB) Act – a commonsense bipartisan bill that would take steps to mitigateContinue Reading »...
  • ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar

    October 15, 2019
    Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association (ACLA) has filed a motion for summary judgment before the U.S. District Court for the District of Columbia challenging the flawed implementation of the Protecting Access to Medicare Act (PAMA) in the final rule promulgated by the U.S. DepartmentContinue Reading »...
  • ACLA Deeply Concerned by FDA Actions on Pharmacogenetic Testing

    September 18, 2019
    Agency actions limit clinical information for physicians and patients, undermine Congress and ongoing diagnostic reform efforts Washington, D.C. – In response to the U.S. Food and Drug Administration (FDA)’s troubling actions against pharmacogenetic (PGx) testing, ACLA urged the agency to immediately reconsider and reverse its recent decisions in light of the significant harm and consequences to patient care. Taken together, FDA’s actions appear toContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17